Abstract Hepatic encephalopathy (HE) is a serious complication of liver disease and portosystemic shunting that represents a continuum of neuropsychiatric changes and altered consciousness. It is classified as overt HE (OHE) when clinically apparent or as covert HE (CHE) in its mildest form. Progression of CHE to OHE and its impact of quality of life make its early diagnosis imperative. Several diagnostic techniques ranging from simple clinical scales to sophisticated computerized tests exist, yet diagnosis remains a challenge, due to the time, cost, and personnel involved. Psychometric tests appear promising due to their high sensitivity and low cost, but results are variable depending on age and education. The pros and cons of current diagnostic methods for OHE and CHE are reviewed, along with strategy for CHE testing.
Introduction
Hepatic encephalopathy (HE) is a spectrum of neuropsychiatric abnormalities seen in patients with liver dysfunction and portal-systemic shunting diagnosed after exclusion of other known brain diseases [1] . It affects 30 %-45 % of patients with cirrhosis, and its presence and degree of progression signify poor prognosis and high mortality [2] . The Working Party at the 11th World Congress of Gastroenterology, Vienna, under the Organization Mondiale de Gastroentrologie proposed a multiaxial definition of HE that defined both the type of hepatic abnormality and the duration and characteristics of neurological manifestations in chronic liver disease. Type A HE is due to acute liver failure, type B is attributable to portosystemic shunt or bypass, and type C is due to cirrhosis. Type C HE can be further subclassified into episodic, persistent, and minimal [1] .
On the basis of clinical and neuropsychometric testing, HE can be categorized as overt or covert. HE that is clinically apparent is termed overt HE (OHE). HE that is mild without an obvious clinical profile and diagnosed only by specialized cognitive testing is termed covert HE (CHE), previously known as minimal or subclinical HE.
Over the past decade, CHE has received growing interest due to its prognostic importance for the development of OHE [3] . It has a characteristic cognitive profile that cannot be diagnosed clinically [1, [4] [5] [6] . CHE is known to be associated with deficits in driving skills [7] [8] [9] , reduction in quality of life [10, 11] , impairment of working capability [3, 12] , and, most important, predicting the subsequent onset of overt HE [13] [14] [15] [16] . CHE is associated with poor prognosis and is an independent predictor of survival [17] . In recognition of the dangerous consequences of CHE, the name of the condition has recently been changed from minimal to covert, a position endorsed by the International Society for Hepatic Encephalopathy and Nitrogen Metabolism [18••] .
Search Criteria
A PubMed search was conducted using MeSH term "Hepatic Encephalopathy/diagnosis" between the dates of 1/1/2009 and 31/12/2013, yielding 309 articles total. Articles were reviewed on the basis of their relevance to the topic. The Hepatic Encephalopathy Update: Reports from Recent Conferences 2013 International Liver Conference was also reviewed.
Tests for Grading the Severity of Overt Hepatic Encephalopathy
Clinical Diagnosis OHE is diagnosed clinically on the basis of two types of symptoms: impaired mental status, as defined by the West Haven Criteria (WHC), and impaired neuromotor function [19] . The current standard for grading HE is based on clinical diagnosis; hence, a thorough history and physical exam are imperative. OHE can be further subdivided into episodic or persistent and precipitated or spontaneously occurring [19] .
OHE remains a diagnosis of exclusion, and other causes of altered mentation in cirrhotic patients should be investigated before considering this particular diagnosis.
Ammonia Levels
Since ammonia has been regarded as the key precipitating factor, plasma ammonia levels are used widely in patients with cirrhosis and altered mental status to diagnose HE [20, 21] . It represents a common conception that increased ammonia levels in a cirrhotic patient can confirm, or rule out, HE. However, the degree of correlation between ammonia levels and the grading of HE continues to be controversial.
Gundling et al. evaluated, in a prospective study in an emergency department setting, whether elevated blood ammonia levels coincide with HE, which was additionally established by the WHC and the critical flicker frequency, respectively, and found that ammonia blood levels do not reliably detect HE. Its use as sole indicator for HE in emergency departments may result in frequent misinterpretations [22] .
Grading of Overt Hepatic Encephalopathy

West Haven Criteria
The well-known WHC (Conn score) is based upon impairment in consciousness, intellectual function, and behavior [1] . It classifies HE into five grades of severity. Grade 0 represents patients without detectable changes in personality or behavior; grade I includes patients with trivial lack of awareness, shortened attention span, and altered sleep and mood; and grades II-IV represent OHE and coma. To avoid missing the lower grades of HE, the presence of HE should be evaluated by using the Mini-Mental Status Exam (MMSE), which examines memory and attention in a systematic manner.
The WHC is recommended by the Working Party on Hepatic Encephalopathy for assessment of OHE in clinical trials [1] . In a recent study by Bass et al. [23••] evaluating the efficacy of rifaximin in preventing relapse of HE in patients with OHE, the investigators used the WHC to grade stages of HE by implementing the hepatic encephalopathy scoring algorithm (HESA) [24] .
Hepatic Encephalopathy Scoring Algorithm
The HESA, originally devised for use in a multicenter study by Hassanein et al. to assess the utility of extracorporeal albumin dialysis in the treatment of patients with severe HE (grades III/IV), may be particularly useful for assessing patients with low grades of HE, since minimal variability was detected between the scores given at the different study sites [25] . The HESA combines clinical indicators with those derived from simple neuropsychological tests, the latter more often used in milder grades of HE (grades I/II). The performance of each indicator is compared across grades and sites [26] . The HESA is simple, time efficient, and sensitive to subtle brain changes, like the WHC, but offers a more objective approach, which should yield greater reliability across the spectrum of HE. However, the length of the HESA makes it difficult to apply in clinical practice.
Clinical Hepatic Encephalopathy Staging Scale
The Clinical Hepatic Encephalopathy Staging Scale (CHESS) [27] was designed to monitor the severity of HE on a scale from 0 (low ) to 9 (high ) and with the aim of reducing interobserver variability. These questions have been used in two recent randomized clinical trials (Simon-Talero et al. and Rockey et al.) [28••, 29•] .
Modfied-Orientation Log
The modified-orientation log (MO-log) is an eight-question adaptation of the orientation developed by Novack et al. [30] in traumatic brain injury and extends it to HE. Its questions are heavily weighted toward disorientation with respect to time, which is the earliest form of disorientation in OHE. The subjects are asked a particular question, and responses to logical cues and multiple choice questions are studied in case the orientation question is not answered correctly; the highest score is 24, and the lowest is 0. In their study, Salam et al. concluded that the MO-log is a valid tool for assessing severity and is better than the WHC in predicting outcomes in hospitalized HE patients, and the change in MO-log over the first 24 h of hospitalization was especially important in predicting outcomes [31••] .
Glasgow Coma Scale
For deeper grades of coma in which patients are not verbally responsive, there are no specific HE questionnaires, but the validated Glasgow Coma Scale (GCS) can be utilized. The GCS adds to the assessment of severe HE by providing a wider separation for cases where grades III and IVare present. The study by Hassanein et al. indicates weak performance of the GCS in lower grades of HE [26] .
Summary of Overt Hepatic Encephalopathy Grading
Therefore, the current grading of OHE requires further study beyond the WHC and its modifications. Simple questionnaires, such as CHESS and MO-log, can divide the patients' mental status into 9 and 24 levels, respectively. The GCS can be used for patients who are not responsive to questionnaires.
Diagnostic Testing for Covert Hepatic Encephalopathy
Standardization of screening tools for diagnosis of CHE remains a vital issue. The Hepatic Encephalopathy Consensus Group at the World Congress of Gastroenterology in 1998 endorsed the Psychometric Hepatic Encephalopathy score (PHES) as the gold standard for diagnosing CHE [1] . Over the past decade, several drawbacks of this testing system have been identified, such as test administration and scoring in the outpatient setting. Although the PHES is popular in Europe, and elsewhere it has failed to gain widespread acceptance in the United States, mainly because of copyright issues and the lack of availability of testing material [9] .
CHE does not have a clinically apparent profile; hence, clinical diagnostic testing cannot be used. The ideal test for CHE diagnosis would be a quick, cheap, reliable, readily available, easy-to-administer test that accurately predict outcomes. The consequences of CHE for daily living even though patients are asymptomatic [32] has led to the need for screening tests and early detection. Neuropsychological and neurophysiological methods have been the most trusted and widely used tests for diagnosing CHE [1, 4, 5] . These tests should be easy to use and quantifiable and should assess the cognitive domain: attention deficit and slow information processing, which are the most prominent disturbances in CHE [33] . A number of computerized psychometric testing systems are being validated for the diagnosis of CHE, but they are not yet at a stage at which they can be implemented or endorsed globally.
Neuropsychometric Tests
Neuropsychological or neuropsychometric tests include both "paper-and-pencil" tests and computerized tests that can be used to identify impairments in visuospatial functioning, attention, processing speed, and response inhibition [34] . These tests are cheap and easy to administer and do not require experienced personnel or expensive equipment. However, their dependence on a patient's age and education, total testing time, and applicability restricted to lower grades of HE confers a disadvantage to diagnosis of HE. Present international consensus recommends use of the PHES or the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) for diagnosing and monitoring CHE, depending on availability of local normative data [35] .
Paper-and-Pencil Tests
Psychometric Hepatic Encephalopathy Score The PHES is the current "gold standard" pencil-and-paper test battery for the psychometric evaluation of patients with HE, standardized and validated by Weissenborn and colleagues [34] . This battery measures psychomotor speed and precision, visual perception, visuospatial orientation, visual construction, concentration, attention, and memory, is simple to perform, and can be completed in less than 20 min [36] . The PHES initially comprised seven tests, but the desire for a shorter battery and the poor sensitivity of some of the tests led to the introduction of a revised battery called the Portosystemic Encephalopathy (PSE) Syndrome Test, which includes the line tracing test, serial dotting test, digit symbol test, and number connection tests A and B (NCT A and B). The sensitivity and specificity of the PHES, as compared with the standard method of determining HE grade, were 96 % and 100 %, respectively [36] . Standard normative data of the PHES have been developed in German, Spanish, and Italian. Thus the PHES is the predominant strategy for CHE detection outside the US [24] . Performing this battery can be time consuming and prone to bias from disturbance, mood, and interaction with the tester [37••] . This is not available directly in the U.S., and there are no nationwide norms for this. However, it can be obtained through the International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN).
Repeatable Battery for the Assessment of Neuropsychological Status
The RBANS is a 20-to 25-min paper-and-pencil battery used to diagnose neurocognitive disorders such as dementia, traumatic brain injury, stroke, multiple sclerosis, and bipolar disorder. It evaluates global cognitive functioning on the basis of language, visual perception, attention, immediate memory, and delayed memory. Although a few studies have now confirmed its usefulness in characterizing cognitive impairment in liver transplant candidates [38, 39] and the ISHEN recommended its use in patients for CHE [35] , there are limited data to support its use, since two of its domains, delayed memory and language, are not usually impaired in CHE. A modified version of the RBANS that takes about 20-25 min to administer has been designed to focus specifically on the cognitive changes that occur in patients with OHE [35] and has proven to be effective in screening patients for CHE [39] . The RBANS is available for a fee in the U.S. through Psychological Corporation Inc.
Computerized Tests
Paper-and-pencil tests rely heavily on the motor function of the patient and involve multiple cognitive functions for their successful completion. However, computerized testing affords greater control over task stimuli and standardization of presentation, allowing specific cognitive processes to be assessed [40] .
Inhibitory Control Test
showed that lure responses greater than 5 out of 40 attempts could detect CHE with high sensitivity. Lower lure response, higher target response, and shorter RTs indicate a good performance [41] . However, another study reported that lures alone were not sensitive in detecting CHE; target accuracy and lures weighted by target accuracy showed better discriminating values between healthy controls and patients with minimal hepatic encephalopathy (MHE) [42] . Studies evaluating driving showed that ICT performance was significantly associated with driving simulator performance and traffic accidents [41, 43] . The ICT is a sensitive, inexpensive, and easily administered test with good external validity and test-retest reliability, which makes it a good candidate as a diagnostic tool for CHE [44] . Like other neuropsychological measures, the ICT is influenced by prior exposure [42] . This is available for free download at www.hecme.tv.
Cognitive Drug Research
The Cognitive Drug Research (CDR) battery assesses five cognitive areas, including attention power, attention continuity, speed of memory, and quality of episodic and working memory, via a set of increasingly complex tasks based on yes/no responses that are inputted via a decision box by the patient after the initial learning period. The CDR has shown good correlation with the gold standard PHES test, is well validated across population norms and disease states, including many forms of dementia and psychiatric conditions, and has recently been validated in patients with HE [40] . It does not have U.S.-based norms but is available for a fee from the U.K.
Scan Test Montagnese et al. from
Italy assessed the usefulness of the Scan package, a three-level-difficulty computerized RT test, in diagnosing varying degrees of HE [45•] . The first level is a simple RT, where the subject is asked to respond to a series of visual stimuli (an asterisk on the computer screen) by pressing the space bar on the keyboard. Level two is the choice RT, where the subject is presented with either the number 1 or the number 3 on the computer screen and is asked to press 1 or 3 on the keyboard accordingly. Level three is the scan RT, which is a digit recognition task based on the Sternberg paradigm and has previously been shown to be a useful test in patients with cirrhosis [17, 46] . The subject is presented with 36 consecutive pairs of numbers and is asked to press 1 on the keyboard if there are digits in common or press 3 if there are not. For all three levels, the number of correct responses, expressed as a percentage of the total number of stimuli (accuracy), and the accuracy-adjusted, average RT (in milliseconds) are calculated. Limitations to this study included that while the Scan test software provides an overall Z score, which is corrected for age/educational attainment, the presented weighed RTs were not normalized and should be considered valid for populations of patients with cirrhosis similar to that used in this study [45•] . Amodio and colleagues found that, among various types of psychometric tests such as the Trail-Making Tests and Symbol Digit Modality Tests, the scan test was the most closely related to central brain atrophy [47] . About 50 % of cirrhotic patients performed poorly on the scan test, making it valuable in detecting the neuropsychological impairment caused by cirrhosis. Furthermore, patients who had a history of OHE performed significantly worse than those who never had a bout of OHE [24] . This, however, is not available in the U.S.
STROOP App Test
The Stroop smartphone application (EncephalApp_Stroop) was used by Bajaj et al. as a valid, reliable tool to screen for CHE [48••] . The Stroop task is a test of psychomotor speed and cognitive flexibility that evaluates the functioning of the anterior attention system and has been found to be sensitive for the detection of cognitive impairment in CHE [49] . The EncephalApp_Stroop (available on iTunes for free download) is easy to administer and simple to score and interpret. This new app has cutoffs that are age specific but need to be validated in other populations. The details of its download, interpretation, and administration can be viewed as webcasts at www.chronicliverdisease.org.
Neurophysiological Tests
Critical Flicker Frequency
Critical flicker frequency (CFF) can detect a range of neuropsychological abnormalities from visual signal processing to cognitive functions, making it a valuable tool in various fields, including hepatology, neurology, psychiatry, and ophthalmology [15, 50, 51] . Patients are shown light pulses at an initial frequency of 60 Hz, gradually reduced by 0.1 Hz decrements per second. Patients are asked to identify the time at which the apparently steady fused light begins to flicker. A critical flicker frequency of below 39 Hz diagnoses CHE with high sensitivity and specificity, and test results correlate positively with those of the paper-and-pencil neuropsychometric test [52] . Most published studies agree that the sensitivity and specificity of CFF diagnosing CHE are 80 % and 65 %, respectively [53] . The CFF has the advantage of not being dependent on language, verbal fluency, numeracy, or numerics, and therefore studies into its use have been performed in the U.S., Europe, and Asia [37] . It is a simple, easy-to-use, and reliable tool that is independent of education, gender, age, and literacy.
In recent studies by Sharma et al., the CFF has been evaluated as an objective measure for grading CHE, as well as assessing recovery of patients with cirrhosis from sedation after endoscopy [53, 54] . Other studies assessed the use of CFF as a marker for objective HE evaluation in patients undergoing transjugular intrahepatic portosystemic shunt [52, 55] . Romero-Gomez et al. in their study found that CFF together with Child-Pugh class can predict the development of HE grades II and I in follow-up [15] . However, further validation and standardization studies are needed to determine its use and applicability in differentiating between HE grades 0 and I. It is not useful in grade III or IV HE either, because patients' attention and cooperation are required. Thus, CFF has not been established as a diagnostic tool in OHE. A meta-analysis by Torlot et al. [37••] has shown that CFF is a diagnostically accurate test, which could be used as an adjunct to conventional psychometric test batteries, such as PHES, but could become a replacement screening test only if further studies show an improvement in sensitivity.
Electroencephalogram
Similar to clinical grading, the electroencephalogram (EEG) classifies HE in five grades of severity from normal to coma. In published studies, the diagnostic sensitivity for HE ranges between 43 % and 100 % [34] . In mild HE, the increase in confusion is associated with the initial EEG tracings that reveal posterior dominant alpha rhythm slowing, which is typically followed by a gradual appearance of theta and high-amplitude irregular delta waves as the HE progresses into coma. This neurophysiological method is associated with both inter-and intraobserver variability, leading some to suggest a lack of objectivity [56] . An alternative objective approach is spectral analysis of the EEG, which is a computerized analysis of the frequency distribution in the EEG. Spectral analysis of the EEG is a simple technique, is more reliable than visual EEG reading, and has prognostic value for the development of HE and mortality in cirrhotic patients [57, 58] . Digital analysis of the EEG analyses [59] .
Evoked Potentials
Visual, auditory, and somatosensory-evoked potentials have been investigated in patients with HE, but their use is limited in patients with OHE due to patient cooperation. Both auditory and visual P300 have been shown to have diagnostic potential in mild HE but are nonspecific to HE and are not recommended, because of inconsistent results [60] . The P300 is an event-related potential that is elicited by low-probability target items interspersed among highprobability nonstimuli. In response to the oddball stimuli, the brain shows an EEG recognition response at approximately 300-600 ms. A delay response greater than 300 ms indicates brain impairment [24] . Auditory P300 potentials have been used independently and may have value in the diagnosis of CHE. However, the absence of clear cutoffs and guidelines for the sensitivity and specificity that define CHE limit their clinical usefulness. Some researchers suggest that expensive equipment, low sensitivity, and the lack of accompanying behavioral information are drawbacks of these methods [61, 62] .
Summary for Covert Hepatic Encephalopathy Testing in Clinical Practice
A summary of relative advantages, disadvantages, and availability of certain tests are listed in Table 1 . A suggested checklist and an order of testing that could be used for CHE in US-based clinics are also displayed in Tables 2 and 3 , respectively.
Conclusions
A survey among members of the American Association for the Study of Liver Diseases (AASLD) showed that 72 % tested fewer than half their patients for CHE, despite 84 % acknowledging that CHE is a significant problem. Furthermore, 85 % said that if clinical staff could perform a quick, accurate test, this would increase the likelihood that people would test for CHE [63] . There is no single ideal test that accurately covers the spectrum of HE, from minimal changes to deep coma [26] . EEG, which can be done across the spectrum of HE, has not been shown to have a high degree of precision for metabolic encephalopathies [64] . The rest of the tests work at either the beginning or the end of the spectrum of neurocognitive impairment in cirrhosis [65••] . Tests for CHE are slowly but steadily making their way into the mainstream, with the focus being on end-user ease and cost-effective methods of implementation of these strategies to maximize local resources. Continued research into this very important field is continuing and further validation studies will be available soon. Table 3 Suggested practical covert hepatic encephalopathy treatment strategy in order 1. Identify patients at risk and counsel them that these tests could be needed for evaluation of their overall daily functioning 2. Train clinic nurses/research personnel/medical assistants/mid-level professionals to administer a high-sensitivity test that can determine who does not need formal testing while the patient is waiting to be seen by you in clinic in a separate quiet area 3. Consider using these results that would be given to you by the medical assistants when the patient is seen by you in clinic 4. Interpret these results to determine who needs formal testing at a separate clinic visit with personnel who have expertise in testing-e.g., psychologists or psychiatrists 5. Evaluate the interpretation of the qualified personnel and offer treatment trials if requested by the patient; if patients are unimpaired, can consider retesting in 6 months or sooner if the natural history of the patient changes. 
